Tri Locum Partners LP Akero Therapeutics, Inc. Transaction History

Tri Locum Partners LP

  • $374 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$37.27 - $50.24 $1.5 Million - $2.03 Million
-40,327 Reduced 31.3%
88,524 $3.39 Million
Q4 2022

Feb 14, 2023
SELL
$33.44 - $54.8 $2.69 Million - $4.41 Million
-80,397 Reduced 38.42%
128,851 $7.06 Million
Q3 2022

Nov 14, 2022
BUY
$10.15 - $34.05 $2.12 Million - $7.12 Million
209,248 New
209,248 $7.13 Million

Others Institutions Holding AKRO

# of Institutions
190
Shares Held
73.8M
Call Options Held
241K
Put Options Held
647K
View Full List

About Akero Therapeutics, Inc.

AKRO Quotes by TradingView
  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $1.52B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email